Tami Pilot-Matias Selected Research

Tami Pilot-Matias Research Topics

31	Infections 10/2019 - 06/2007
20	Fibrosis (Cirrhosis) 10/2019 - 01/2014
7	Chronic Hepatitis C 03/2019 - 07/2013
3	Hepatitis C 03/2019 - 01/2013
3	Virus Diseases (Viral Diseases) 01/2019 - 06/2015
2	Anemia 01/2017 - 12/2014
2	Coinfection 01/2017 - 03/2015
2	Body Weight (Weight, Body) 04/2014 - 01/2014
1	Liver Diseases (Liver Disease) 10/2019
1	Chronic Renal Insufficiency 10/2019
1	Nasopharyngitis 01/2017

22	Ribavirin (Virazole)FDA LinkGeneric 10/2019 - 01/2013
21	paritaprevirIBA 03/2019 - 01/2013
20	ombitasvirIBA 03/2019 - 01/2014
19	Ritonavir (Norvir)FDA Link 03/2019 - 01/2013
16	InterferonsIBA 03/2019 - 01/2013
13	Antiviral Agents (Antivirals)IBA 10/2019 - 01/2013
9	dasabuvirIBA 01/2019 - 01/2013
7	glecaprevir and pibrentasvirIBA 10/2019 - 01/2018
7	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 01/2013
6	RNA (Ribonucleic Acid)IBA 01/2017 - 03/2015
5	SofosbuvirIBA 03/2019 - 01/2018
4	pibrentasvirIBA 10/2019 - 01/2018
4	glecaprevirIBA 10/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 01/2017
2	Atazanavir Sulfate (Reyataz)FDA Link 01/2017 - 03/2015
2	Raltegravir Potassium FDA Link 01/2017 - 03/2015
2	telaprevirIBA 04/2014 - 04/2014
1	ledipasvirIBA 01/2019
1	QuartzIBA 01/2019
1	Viekira PakIBA 10/2018
1	daclatasvirIBA 01/2018
1	BilirubinIBA 01/2017
1	Darunavir (Prezista)FDA Link 01/2017
1	dolutegravirIBA 01/2017
1	Hepatitis C AntibodiesIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 11/2015
1	dimemorfan (AT 17)IBA 03/2015
1	Peptide Hydrolases (Proteases)FDA Link 02/2015
1	TabletsIBA 04/2014
1	PlacebosIBA 04/2014